Venus Remedies Renews GMP Certification in Ukraine, Boosting Global Expansion
Venus Remedies has successfully renewed its GMP certification from Ukraine's SMDC, covering its Baddi manufacturing facility. This certification strengthens their presence in Ukraine and aids penetration into PIC/S markets. Ukraine's pharmaceutical market is projected to grow, driven by generics and oncology demands.

- Country:
- India
Venus Remedies, a leading pharmaceutical company, announced the successful renewal of its good manufacturing practices (GMP) certification from Ukraine's State Service on Medicines and Drugs Control (SMDC) on Saturday.
The certification covers the company's Unit-II manufacturing facility in Baddi, Himachal Pradesh, which produces cephalosporin, non-cephalosporin (carbapenem), and oncology parenteral products, including liquid and lyophilized injections.
With this renewed certification, Venus Remedies strengthens its position in the Ukrainian market and opens doors to the wider Pharmaceutical Inspection Co-operation Scheme (PIC/S) markets, amplifying their international growth prospects.
(With inputs from agencies.)
ALSO READ
Goa's High-Tech Leap: Electronic Manufacturing Cluster Set to Transform Tuem
TSMC's Revenue Soars Amid Semiconductor Surge: A Look into the Future of Chip Manufacturing
Tariff Troubles: How Trump's Trade War Is Shaking Up Toy Manufacturing
NxtCell India Revives Alcatel with Local Manufacturing Boost
Strengthening Local Manufacturing: DPIIT's Proposal for Tender Scrutiny